Netarsudil
Netarsudil
Netarsudil (pronunciation: neh-tar-SOO-dil) is a medication used in the treatment of glaucoma and ocular hypertension. It is often marketed under the brand name Rhopressa.
Etymology
The name "Netarsudil" is derived from the chemical structure of the drug. "Netar" is a reference to the netarsudil dimesylate, the active ingredient in the drug, and "sudil" is a common suffix used in the naming of pharmaceutical drugs.
Usage
Netarsudil is used to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. It is a Rho kinase inhibitor, which works by increasing the outflow of aqueous humor, the fluid in the eye, thereby reducing the pressure.
Related Terms
- Glaucoma: A group of eye conditions that damage the optic nerve, often caused by an abnormally high pressure in your eye.
- Ocular hypertension: A condition characterized by an increase in pressure in the eyes due to a buildup of fluid.
- Intraocular pressure (IOP): The fluid pressure inside the eye.
- Aqueous humor: The clear fluid filling the space in the front of the eyeball between the lens and the cornea.
- Rho kinase inhibitor: A type of drug that inhibits the Rho kinase enzyme, which is involved in the regulation of the shape and movement of cells.
Side Effects
Common side effects of Netarsudil include conjunctival hyperemia (red eyes), cornea verticillata (deposits in the cornea), and mild to moderate conjunctival hemorrhage (bleeding in the eye).
External links
- Medical encyclopedia article on Netarsudil
- Wikipedia's article - Netarsudil
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski